Acumen Pharmaceuticals In... (ABOS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.03

0.00%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	-	-	-	1.44M	1.70M
Cost of Revenue	42.32M	169.00K	4.00K	8.00K	8.58K
Gross Profit	-42.32M	-169.00K	-4.00K	1.43M	1.69M
Operating Income	-61.14M	-45.24M	61.57M	-7.91M	-7.80M
Interest Income	10.21M	2.39M	84.00K	1K	45.00K
Pretax Income	-52.37M	-42.86M	-100.61M	-7.33M	-7.91M
Net Income	-52.37M	-40.48M	-181.68M	-7.32M	-7.86M
Selling & General & Admin	18.82M	12.88M	7.28M	1.35M	926.00K
Research & Development	42.32M	32.36M	12.30M	8.00M	8.58M
Other Expenses	-	-11.00K	51.00K	-	-
Operating Expenses	61.14M	45.24M	19.58M	9.35M	9.50M
Interest Expense	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	61.14M	45.24M	19.58M	9.35M	9.50M
Income Tax	-	-2.38M	81.07M	-1K	-45.00K
Shares Outstanding (Basic)	48.49M	40.60M	40.47M	40.15M	40.15M
Shares Outstanding (Diluted)	48.61M	40.60M	40.47M	40.15M	40.15M
EPS (Basic)	-1.08	-1	-4.49	-0.18	-0.2
EPS (Diluted)	-1.08	-1	-4.49	-0.18	-0.2
EBITDA	-51.61M	-42.69M	61.58M	587.00K	119.00K
Depreciation & Amortization	184.00K	169.00K	4.00K	7.91M	7.80M